Cite
Clotet-Freixas S, Kotlyar M, McEvoy CM, et al. Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection. Transplant Direct. 2021;7(10):e768doi: 10.1097/TXD.0000000000001215.
Clotet-Freixas, S., Kotlyar, M., McEvoy, C. M., Pastrello, C., Rodríguez-Ramírez, S., Farkona, S., Cardinal, H., Dieudé, M., Hébert, M. J., Li, Y., Famure, O., Chen, P., Kim, S. J., Chan, E., Jurisica, I., John, R., Chruscinski, A., & Konvalinka, A. (2021). Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection. Transplantation direct, 7(10), e768. https://doi.org/10.1097/TXD.0000000000001215
Clotet-Freixas, Sergi, et al. "Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection." Transplantation direct vol. 7,10 (2021): e768. doi: https://doi.org/10.1097/TXD.0000000000001215
Clotet-Freixas S, Kotlyar M, McEvoy CM, Pastrello C, Rodríguez-Ramírez S, Farkona S, Cardinal H, Dieudé M, Hébert MJ, Li Y, Famure O, Chen P, Kim SJ, Chan E, Jurisica I, John R, Chruscinski A, Konvalinka A. Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection. Transplant Direct. 2021 Sep 20;7(10):e768. doi: 10.1097/TXD.0000000000001215. eCollection 2021 Oct. PMID: 34557585; PMCID: PMC8454907.
Copy
Download .nbib